Artivion | CRY - 营业费用

金融业

USD 20.21

USD 1.04B

现金及等价物

USD 48.4M

USD 42.85M

USD 338.81M

USD 76.66M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 446.4M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 363.79M

USD 1.04B

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 107.05M

贸易债权人

USD 17.63M

应收帐款人

USD 103.68M

	营业费用	更改		日
Abbott	USD 11.66B		1.2B	2026-09
Accuray	USD 37.18M		567K	2024-12
AngioDynamics	USD 81.95M		1.68M	2025-09
Artivion	USD 111.2M		9.45M	2025-12
AtriCure	USD 150.1M		6.16M	2026-09
Baxter International	USD 6.5B		3.82B	2026-09
Becton, Dickinson and Co.	USD 4.16B		20.25B	2026-09
Boston Scientific	USD 4.13B		72M	2026-09
Edwards Lifesciences	USD 10.86B		9.64B	2026-09
Inogen	USD 49.14M		665K	2024-09
Integra LifeSciences	USD 368.53M		674.84M	2026-09
J&J	USD 18.93B		1.09B	2026-09
Mesa Laboratories	USD 33.98M		2.03M	2024-12
Orthofix International	USD 213.79M		12.36M	2025-12
Pfizer	USD 89B		3.81B	2026-09
ResMed	USD 1.01B		83.57M	2026-06
Stryker	USD 4.8B		118M	2026-06
Tandem Diabetes Care	USD 286.06M		17.71M	2026-09
Teleflex	USD 3.49B		589.18M	2026-09
Terumo	JPY 222.33B		46.54B	2026-06
Trinity Biotech	USD 12.63M		255K	2026-03